Searched for
LABORATE PHARMACEUTICALS INDIA LTD
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...- Raghuram Rajan's warning to India after Hormuz shock: Build bigger oil reserves, diversify fasterGlobal economic shocks from trade disruptions and geopolitical tensions are reshaping resilience, according to Raghuram Rajan. He stresses ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 36%Whether you are a trader or an investor, there is one thing to watch carefully in the coming days: Earnings. The reason why this is importa...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...
- Graph AI raises $3 million seed funding for drug safety platformAI life sciences startup Graph AI has secured $3 million in seed funding to revolutionise pharmacovigilance. The California-based startup l...
- India's chemical and pharmaceutical industry gains traction as Europe faces decline: NuvamaIndia is establishing itself in the global CDMO sector, driven by government incentives and low operational costs, making it an attractive ...
- Union Budget: What lies ahead for Modi's flagship PLI scheme?As India prepares for Budget 2024, the spotlight is on Production-Linked Incentive (PLI) schemes, crucial for revitalizing manufacturing an...
- Authorities cancel licences of several drug companies for lapsesRegulators had inspected dozens of drug manufacturing units in Himachal Pradesh, Uttarakhand, Haryana, Madhya Pradesh and Maharashtra, foll...
- India could soon experience heat waves that break human survivability limit: World Bank reportSevere heat waves, responsible for thousands of deaths across India over the last few decades, are increasing with alarming frequency and s...
- India could soon experience heat waves that break human survivability limit: World Bank report"In April 2022, India was plunged into the grip of a punishing early spring heat wave that brought the country to a standstill, with temper...
- India, UK launch FTA talks, sensitive issues not a priority: Piyush GoyalCommerce and industry minister Piyush Goyal and Anne-Marie Trevelyan, UK Secretary of State for International Trade launched the trade pact...
- Will tariffs on India work? Here's a shiny clueSince general US tariffs are fairly low now, India can afford to ignore the threat to its $5.6 bn of exports.
- SEZ for only Indian companies in Tashkent soonPlans are afoot for setting up an SEZ in Uzbekistan especially for Indian pharmaceutical companies, which are keen to set up manufacturing ...
- Australian university to provide medical technology to IndiaNeuroscience leaders from Swinburne signed one agreement with Medanta, one of India's largest private hospitals, on a project to improve th...
- HC to resume hearing on pharma cos' pleas against Centre's orderThe companies have contended that the decision was taken by the government without issuing them a show cause notice or granting them a hear...
- High Court stays prosecution over multi-dose diclofenacIt was not made clear as to why the multi-dose package had been prohibited while the medicine was permitted for human use as an essential d...
- India needs to look at IPR norms more closely: USTR FromanDuring a meeting with representatives from another industry chamber FICCI also, Froman said it was in India's interest to have a strong and...
- Dr Reddy's, Sun Pharma among 14 firms probed by US Congress over drug price"When you see how much the prices of these drugs have increased just over the past year, it's staggering, and we want to know why," said Cu...
- Drugs pricing row: 4 pharma firms move HC against government orderFour pharma firms today moved the Delhi High Court challenging government's new drug pricing order that asked them to slash prices of certa...
- Bulk drug suppliers to come under FDA lensThe US Food & Drug Administration has been asked by a US senator to probe into outsourcing of pharma ingredients. Ranbaxy sell-off
Load More
